# Pharma \& Medtech Webinars \| GMP Webinars \& Training Courses: Driving Quality \& Excellence in GMP\| GDP \| GLP With Engaging Digital Content

> Join Qualistery for expert\-led life science webinars and content on the latest trends in regulated fields: Pharma, Biotech, MedTech\.

Generated by Yoast SEO v27.4, this is an llms.txt file, meant for consumption by LLMs.

## Pages
- [Life Sciences: Pharma, Medtech \& Biotech Webinars \- Homepage](https://qualistery.com/)
- [Pharma Webinars — Free Live \& On‑Demand Training for GxP Professionals](https://qualistery.com/pharma-webinars-free-live-on‑demand-training-for-gxp-professionals/)
- [Free GMP Webinars](https://qualistery.com/gmp-training-online-live-courses/)
- [The GxP Knowledge Hub \- Copy](https://qualistery.com/the-gxp-knowledge-hub-copy/)
- [The GxP Knowledge Hub](https://qualistery.com/the-gxp-knowledge-hub/)

## Posts
- [Digital Guardrails: EMA’s Ban on GenAI and the Death of the Paper Leaflet](https://qualistery.com/digital-guardrails-emas-ban-on-genai-and-the-death-of-the-paper-leaflet/): The ground under pharmaceutical manufacturing just shifted\. From the FDA’s new "15\-day" enforcement of 483 responses to the EMA’s definitive line in the sand regarding AI in the cleanroom, we are witnessing a full\-scale regulatory renovation\. In the premiere episode of \*The Golden Batch\*, we break down why executive accountability is no longer optional, how $2 billion "megasites" are reshaping the global supply chain, and why the era of the paper patient leaflet is officially coming to an end\. 

If you're in the C\-suite, the Quality office, or managing the line, this is the ground\-truth you need to stay \*\*In Spec\*\* in 2026\.
- [Major pitfalls causing microbial contamination](https://qualistery.com/major-pitfalls-causing-microbial-contamination/): Microbiological contamination control is difficult and can not be improvised at manufacturing operations\. Here we explore the 20 main causes of microbial contamination\. Detailed root\-cause investigation is critical to fully correct the problem, avoid recurrence and mitigate the risk in the future\. 

- [Unlocking Unmet Medical Needs with Full‑Service Partnerships: Insights from NTC Pharma](https://qualistery.com/unlocking-unmet-medical-needs-with-full‑service-partnerships-insights-from-ntc-pharma/): At CPHI Frankfurt 2025, Andrea Boccardi, the Head of Business Franchise at NTC Pharma reveals how NTC has helped their pharma and MedTech clients to  by taking preemptive measures to navigate future regulatory challenges\. 
- [Driving AI\-Ready GxP Manufacturing: Key Takeaways from Aizon](https://qualistery.com/driving-ai-ready-gxp-manufacturing-key-takeaways-from-aizon/): At CPHI Frankfurt 2025, Geri Studebaker, Chief Commercial Officer at Aizon, sheds light
 into the real\-world challenges and next\-step solutions for AI\-driven pharmaceutical manufacturing\.
- [Why Surprise Checks and Specialist Auditors Are Gaining More Attention— Insights from PHARMALANE UK](https://qualistery.com/why-surprise-checks-and-specialist-auditors-are-gaining-more-attention-insights-from-pharmalane-uk/): At CPHI Frankfurt 2025, PHARMALANE UK's CEO Paresh Tank reveals the altering landscape of GMP audits and what roads must quality teams pursue

## Optional
- [Sitemap index](https://qualistery.com/sitemap_index.xml)